⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5904021 | 1.00 | — | — | |
| SCHEMBL4263217 | 1.00 | — | — | |
| Thiophene SCHEMBL28054111 | 0.84 | KDM4E (0.44) | — | |
| SCHEMBL197221 | 0.83 | MAPT (0.50) | — | |
| SCHEMBL69148 | 0.83 | MAPT (0.50) | — | |
| SCHEMBL80875 | 0.83 | MAPT (0.50) | — | |
| SCHEMBL900182 | 0.82 | KDM4E (0.54) | — | |
| SCHEMBL17378062 | 0.82 | KDM4E (0.54) | — | |
| SCHEMBL900178 | 0.82 | KDM4E (0.54) | — | |
| SCHEMBL10977192 | 0.82 | KDM4E (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0792146-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-09-03 | — | — | EP | claimed |
| WO-1997002028-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-01-23 | — | — | WO | claimed |
| CN-117551707-A | Preparation method of S-substituted cysteine, AMA derivative and preparation method thereof | 中国药科大学 | 2024-02-13 | — | — | CN | disclosed |
| CN-110951670-A | Cell culture compositions with antioxidants and methods of polypeptide production | 豪夫迈·罗氏有限公司 | 2020-04-03 | — | — | CN | disclosed |
| CN-105121628-B | Cell culture compositions with antioxidants and methods of polypeptide production | 豪夫迈·罗氏有限公司 | 2020-03-24 | — | — | CN | disclosed |
| US-8263417-B2 | Self-illuminating dot systems and methods of use thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2012-09-11 | — | — | US | disclosed |
| US-20110195138-A1 | Anti-inflammatory cranberry flavonol extract preparations | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2011-08-11 | — | — | US | disclosed |
| US-20090004117-A1 | Self-Illiminating Dot Systems and Methods of Use Thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-01-01 | — | — | US | disclosed |
| EP-0792146-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-09-03 | — | — | EP | disclosed |
| WO-1997002028-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-01-23 | — | — | WO | disclosed |